INFLUENCE OF BACTERIA ON F508DEL CFTR CORRECTION BY VX-809

被引：0
|
作者：
Guimbellot, J. S. [1 ]
Chaudhry, I. G. [1 ]
Quinney, N. L. [1 ]
Cholon, D. M. [1 ]
Esther, C. R. [1 ]
Gentzsch, M. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
PEDIATRIC PULMONOLOGY | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
6
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [1] An Investigational Anti-Cancer Agent Synergizes with VX-809 in F508del Correction
    Ambrosetti, Adam
    Fan, Yifei
    Kirby, Emily F.
    Riggs, Robert M.
    Wang, X. Robert
    FASEB JOURNAL, 2016, 30
  • [2] Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
    Van Goor, Fredrick
    Hadida, Sabine
    Grootenhuis, Peter D. J.
    Burton, Bill
    Stack, Jeffrey H.
    Straley, Kimberly S.
    Decker, Caroline J.
    Miller, Mark
    McCartney, Jason
    Olson, Eric R.
    Wine, Jeffrey J.
    Frizzell, Ray A.
    Ashlock, Melissa
    Negulescu, Paul A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (46) : 18843 - 18848
  • [3] PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF VX-809 IN CYSTIC FIBROSIS SUBJECTS HOMOZYGOUS FOR THE F508DEL MUTATION
    Lu, H.
    Cui, Y.
    Wang, D.
    Vernillet, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S25 - S26
  • [4] IDENTIFICATION OF NOVEL INHIBITORS OF UBIQUITINATION THAT IMPROVE RESCUE OF F508DEL-CFTR BY VX-809
    Goeckeler-Fried, J.
    Estabrooks, S. K.
    Chiang, A.
    Chung, W.
    Ye, Z.
    Denny, R. A.
    Weissman, A. M.
    Camacho, C. J.
    Sorscher, E. J.
    Brodsky, J. L.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 206 - 206
  • [5] VX-809 FACILITATES ΔF508-CFTR TARGETING TO NEUTROPHIL PHAGOSOMES
    Wang, G.
    Zhou, Y.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 298 - 298
  • [6] Combined effects of VX-770 and VX-809 on several functional abnormalities of F508del-CFTR channels
    Kopeikin, Z.
    Yuksek, Z.
    Yang, H. -Y.
    Bompadre, S. G.
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (05) : 508 - 514
  • [7] Discovery of in situ click chemistry compatible analogs of F508del-CFTR corrector VX-809
    Brown, Olivia
    Turlington, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [8] NEGATIVE EFFECTS OF PROLONGED BETA AGONIST AND CAMP TREATMENT ON WT AND VX-809 CORRECTED F508DEL CFTR CURRENTS (BUT NOT CFTR MATURATION) IN HUMAN AIRWAY CELLS
    Kramer, E.
    Backstrom, J. M.
    Ostmann, A. J.
    Sun, H.
    Naren, A.
    Clancy, J. P.
    PEDIATRIC PULMONOLOGY, 2014, 49 : 257 - 257
  • [9] VX-809, AN INVESTIGATIONAL CFTR CORRECTOR, IN COMBINATION WITH VX-770, AN INVESTIGATIONAL CFTR POTENTIATOR, IN SUBJECTS WITH CF AND HOMOZYGOUS FOR THE F508DEL-CFTR MUTATION
    Boyle, M. P.
    Bell, S.
    Konstan, M. W.
    McColley, S. A.
    Wisseh, S.
    Spencer-Green, G.
    PEDIATRIC PULMONOLOGY, 2011, : 287 - 287
  • [10] A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, CLINICAL TRIAL OF FOUR DOSES OF VX-809 IN CF PATIENTS HOMOZYGOUS FOR THE F508DEL CFTR MUTATION
    Clancy, J. P.
    Rowe, S. M.
    Accurso, F. J.
    Ballmann, M.
    Boyle, M. P.
    DeBoeck, C.
    Konstan, M. W.
    Spencer-Green, G.
    PEDIATRIC PULMONOLOGY, 2010, : 298 - 298
12345